A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

PHASE2CompletedINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

June 4, 2020

Study Completion Date

December 14, 2020

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

HS-20004

treatment

Trial Locations (1)

Nanjing Drum Tower hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03848793 - A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects. | Biotech Hunter | Biotech Hunter